Biozipcode, Inc., working in collaboration with Shiga University of Medical Science on the development of a cure for diabetes, will exhibit at ‘BioJapan2022’, held at Pacifico Yokohama from October 12th (Wed) to 14th (Fri), 2022, supported by the Kansai Wide Area Union and Shiga Prefecture.

‘BioJapan2022’ is an exhibition with the following features:

• The largest business matching event in Asia in the life sciences sector.
• An exhibition in the fields of drug discovery, biotechnology, regenerative medicine, and healthcare, aiming for matching with major companies, universities, research institutions, and investors from both Japan and abroad (enabling information dissemination to overseas and all over Japan).
• A partnering matching system that allows participants to pre-schedule meetings and avail of numerous meeting opportunities (including online).

On this occasion, Biozipcode, Inc. will exchange useful information for the development of cures for intractable diseases (such as diabetes, cancer, autoimmune diseases) and explore collaborations with promising future partners.

Biozipcode, Inc. was selected by the Kansai Wide Area Union as one of the companies from Shiga Prefecture and received a paid account to use this matching system. Through this initiative, we aim to accelerate mutual product development and research by meeting with pharmaceutical and health food manufacturers, and research institutions interested in diabetes treatment and regenerative medicine.

For inquiries regarding this matter, please contact us at the following:

Biozipcode, Inc.
Tel: 050-5534-7865
Email: info@biozipcode.com